Hongjian Ji

12PUBLICATIONS
3CO-AUTHORS
Toxicology (incl. clinical toxicology)GlycoconjugatesPharmacogenomicsMedical bacteriologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 04, 2026
Correspondence on "Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach" by Protzenko et al.

Xiaohua Zhou, Yu Shi, Hong Jian Ji

|Jan 12, 2026
Correspondence on "Impact of using different renal function estimation equations on vancomycin dosing" by Gratacós and Soy-Muner.

Xiaohua Zhou, Hong Jian Ji, Hongbao Yang

|Jan 10, 2026
Efficacy and safety of denosumab compared with conventional medications in the treatment of osteoporosis: A meta-analysis with trial sequential analysis.

Liang Li, Jiahao Xu, Hongjian Ji

|Jul 31, 2024
Appropriate therapeutic drug monitoring of vancomycin improves outcomes of patients with bacterial infection in ICU.

Xiaohua Zhou, Hongjian Ji

|Feb 03, 2023
Correspondence on 'Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series'.

Xiaohua Xiao Zhou, Hong Jian Ji

|Jun 09, 2022
A risk prediction model of linezolid-induced thrombocytopenia for elderly patients with chronic kidney disease is urgently needed.

Xiaohua Zhou, Hongjian Ji

Pageof 2

Frequent Collaborators

5 joint publications

Xiaohua Zhou

1 joint publications

Guozhe Zhang

1 joint publications

Fengchao Shi